How to perform and write a systematic review and meta-analysis

참고문헌 (28)

1. Rubin A, "Practitioner's guide to using research for evidence-based practice", pp.48~49 (2022), Wiley
2. D. L Sackett, "Evidence based medicine: what it is and what it isn't", BMJ, 312(7023), pp.71~72 (1996), BMJ[DOI]
3. Nikolaos A. Patsopoulos, "Relative Citation Impact of Various Study Designs in the Health Sciences", JAMA, 293(19), pp.2362~ (2005), American Medical Association (AMA)[DOI]
4. JOHN P.A. IOANNIDIS, "The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta‐analyses", The Milbank Quarterly, 94(3), pp.485~514 (2016), Wiley[DOI]
5. Paul Fontelo, "A review of recent publication trends from top publishing countries", Systematic Reviews, 7(1) (2018), Springer Science and Business Media LLC[DOI]
6. Gaeun Kim, "Overview and recent trends of systematic reviews and meta-analyses in hepatology", Clinical and Molecular Hepatology, 20(2), pp.137~ (2014), The Korean Association for the Study of the Liver[DOI]
7. Maria J. Grant, "A typology of reviews: an analysis of 14 review types and associated methodologies", Health Information & Libraries Journal, 26(2), pp.91~108 (2009), Wiley[DOI]
8. Hilary Arksey, "Scoping studies: towards a methodological framework", International Journal of Social Research Methodology, 8(1), pp.19~32 (2005), Informa UK Limited[DOI]
9. "Cochrane handbook for systematic reviews of interventions version 6.3" (2022)[URL]
10. Valeria Granados-Duque, "Systematic review and meta-analysis: Which pitfalls to avoid during this process", International braz j urol, 47(5), pp.1037~1041 (2021), FapUNIFESP (SciELO)[DOI]
11. "EQUATOR Network"[URL]
12. Matthew J. Page, "The PRISMA 2020 statement: An updated guideline for reporting systematic reviews", PLOS Medicine, 18(3), pp.e1003583~ (2021), Public Library of Science (PLoS)[DOI]
13. Alessandro Liberati, "The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration", Annals of Internal Medicine, 151(4), pp.W~ (2009), American College of Physicians[DOI]
14. "PRISMA 2020 Statement" (2021)[URL]
15. "PRISMA 2020 Checklist" (2021)[URL]
16. "PRISMA 2020 Flow diagram template" (2021)[URL]
17. "Cochrane database of systematic reviews"[URL]
18. "PRO SPERO: International Prospective Register of Systematic Reviews"[URL]
19. J. P. T. Higgins, "The Cochrane Collaboration's tool for assessing risk of bias in randomised trials", BMJ, 343(oct18 2), pp.d5928~d5928 (2011), BMJ[DOI]
20. Jonathan A C Sterne, "RoB 2: a revised tool for assessing risk of bias in randomised trials", BMJ, pp.l4898~ (2019), BMJ[DOI]
21. Jonathan AC Sterne, "ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions", BMJ, pp.i4919~ (2016), BMJ[DOI]
22. "Cochrane methodology. Risk of bias tool for randomized trials (RoB 2)"[URL]
23. "Review Manager 5 (RevMan 5)" (2014)[URL]
24. "Comprehensive meta-analysis (CMA)"[URL]
25. Gordon Guyatt, "GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables", Journal of Clinical Epidemiology, 64(4), pp.383~394 (2011), Elsevier BV[DOI]
26. undefined, "Grading quality of evidence and strength of recommendations", BMJ, 328(7454), pp.1490~ (2004), BMJ[DOI]
27. "GRADEpro guideline development tool" (2015)[URL]
28. Beverley J Shea, "AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both", BMJ, pp.j4008~ (2017), BMJ[DOI]

관련 논문AI추천